| Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity PDA Vignali, K DePeaux, MLJ Watson, C Ye, BR Ford, K Lontos, ... Nature immunology 24 (2), 267-279, 2023 | 90 | 2023 |
| The role of semaphorin 4D in bone remodeling and cancer metastasis K Lontos, J Adamik, A Tsagianni, DL Galson, JM Chirgwin, ... Frontiers in endocrinology 9, 364604, 2018 | 47 | 2018 |
| Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells BR Ford, PDA Vignali, NL Rittenhouse, NE Scharping, R Peralta, ... Science immunology 7 (74), eabj9123, 2022 | 44 | 2022 |
| EZH2 supports osteoclast differentiation and bone resorption via epigenetic and cytoplasmic targets J Adamik, SH Pulugulla, P Zhang, Q Sun, K Lontos, DA Macar, PE Auron, ... Journal of Bone and Mineral Research 35 (1), 181-195, 2020 | 27 | 2020 |
| Primary urinary tract lymphoma: rare but aggressive K Lontos, A Tsagianni, P Msaouel, LJ Appleman, D Nasioudis Anticancer research 37 (12), 6989-6995, 2017 | 19 | 2017 |
| Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis K Saleem, J Franz, ML Klem, JG Yabes, M Boyiadzis, JR Jones, N Shaikh, ... The Lancet Haematology 9 (12), e906-e918, 2022 | 17 | 2022 |
| Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors K Lontos, Y Wang, SK Joshi, AT Frisch, MLJ Watson, A Kumar, AV Menk, ... Journal for Immunotherapy of Cancer 11 (3), 2023 | 14 | 2023 |
| Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date PD Zavras, Y Wang, A Gandhi, K Lontos, GM Delgoffe OncoTargets and therapy, 4543-4554, 2019 | 14 | 2019 |
| A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy C McKeown, A Ricciuti, M Agha, A Raptis, JZ Hou, R Farah, RL Redner, ... Supportive Care in Cancer, 1-7, 2022 | 10 | 2022 |
| Absent falx cerebelli: report of a rare case IN Mavridis, K Lontos, S Anagnostopoulou Anatomical science international 88, 181-182, 2013 | 8 | 2013 |
| Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma K Lontos, JG Yabes, RJ Farah, M Boyiadzis Leukemia 35 (4), 1193-1196, 2021 | 7 | 2021 |
| Acute myeloid leukemia presenting as effusive constrictive pericarditis A Lutz, EB Schelbert, K Lontos, J Rossetti, W Katz CASE 4 (2), 97-102, 2020 | 7 | 2020 |
| Location matters in early stage nodal diffuse large B-cell lymphoma K Lontos, A Tsagianni, JM Yuan, DP Normolle, M Boyiadzis, JZ Hou, ... Leukemia & lymphoma 60 (1), 250-253, 2019 | 6 | 2019 |
| An oncolytic virus–delivered tgfβ Inhibitor overcomes the immunosuppressive tumor microenvironment K DePeaux, DB Rivadeneira, K Lontos, VG Dean, WG Gunn, MLJ Watson, ... Journal of Experimental Medicine 220 (10), e20230053, 2023 | 5 | 2023 |
| HLA factors versus non-HLA factors for haploidentical donor selection RS Mehta, K Cao, RM Saliba, G Al-Atrash, AM Alousi, K Lontos, ... Transplantation and Cellular Therapy 29 (3), 189-198, 2023 | 4 | 2023 |
| Outcomes of patients with acute myeloid leukemia who relapse after 5 years of complete remission A Patel, M Agha, A Raptis, JZ Hou, R Farah, RL Redner, A Im, KA Dorritie, ... Oncology Research 28 (7-8), 811, 2021 | 4 | 2021 |
| Acute myeloid leukemia following gynecologic cancer in the era of platinum-based chemotherapy D Nasioudis, K Lontos, A Tsagianni, M Boyiadzis, EM Ko International Journal of Gynecologic Cancer 28 (8), 2018 | 3 | 2018 |
| EZH2 inhibitor GSK126 exhibits Osteo-Anabolic properties in MM bone disease and synergizes with bortezomib to inhibit MM cell viability J Adamik, R Silbermann, K Lontos, P Zhang, Q Sun, DL Galson, ... Blood 128 (22), 3247, 2016 | 3 | 2016 |
| Time from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia: An analysis of 55 985 patients from the National Cancer Database A Alsouqi, SD Rothenberger, M Boyiadzis, K Lontos British journal of haematology 199 (2), 256-259, 2022 | 2 | 2022 |
| TBK1/Ikkε Inhibitor Amlx Blocks Multiple Myeloma Cell Growth in Vitro and In Vivo Q Sun, P Zhang, J Adamik, K Lontos, V Marchica, N Giuliani, ... Blood 132, 4504, 2018 | 2 | 2018 |
